Is Enanta Pharmaceuticals, Inc. technically bullish or bearish?

As of 10 September 2025, the technical trend for Enanta Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages also indicate a mildly bullish stance. However, the Bollinger Bands show a mixed signal with a mildly bullish weekly outlook and a bearish monthly outlook. The KST is bullish on a weekly basis but bearish monthly, and Dow Theory presents a mildly bearish weekly view alongside a mildly bullish monthly perspective. The OBV is mildly bearish weekly but mildly bullish monthly.
In terms of performance, Enanta Pharmaceuticals has underperformed relative to the S&P 500 over the past week and month, with returns of -9.47% and -4.04% respectively, while the S&P 500 gained 1.05% and 2.33%. However, year-to-date, the stock has outperformed the benchmark with a return of 36.35% compared to the S&P 500's 12.22%. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals across various indicators.